CorMedix CRMD
NASDAQ CRMD
$5.36 -0.01 (-0.19%)
As of: Nov 11, 2026 · 11:55 AM EST

CorMedix (CRMD) Non-Current Deferred Revenue (2014 - 2016)

Updated

CorMedix (CRMD) posted Non-Current Deffered Revenue of $28,878 for Q4 2015.

Analysis

CorMedix (CRMD) Non-Current Deferred Revenue (2014 - 2016) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 CorMedix 417.07 Mn -222.82 Mn 77.13 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2016 22,093.00
Jun 30, 2016 24,349.00
Mar 31, 2016 26,622.00
Dec 31, 2015 28,878.00
Sep 30, 2015 33,391.00
Jun 30, 2015 33,391.00
Mar 31, 2015 35,647.00
Dec 31, 2014 37,903.00
Sep 30, 2014 39,706.00
API Access

CorMedix Non-Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=CRMD&period=max&api_key=YOUR_API_KEY